Efficacy of the combined therapy with Rituximab plus Cyclophosphamide versus Cyclophosphamide as Monotherapy in Systemic Sclerosis-Associated Interstitial Lung Disease

被引：0
|
作者：
Tejeda-Andrade, C. F. [1 ]
Villalpando-Gomez, Y. [1 ]
Gamez-Nava, J., I [1 ]
Castro-Lizano, N. [1 ]
Rocha-Munoz, A. D. [1 ]
Cardona, Munoz E. G. [1 ]
Gonzalez-Lopez, L. [1 ]
机构：
[1] Univ Guadalajara, CUCS, Unidad Invest Cardiovasc, Guadalajara, Jalisco, Mexico
来源：
JOURNAL OF RHEUMATOLOGY | 2011年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1193 / 1193
页数：1
相关论文
共 50 条
  • [1] RITUXIMAB AND CYCLOPHOSPHAMIDE COMPARISON FOR EFFICACY AND SAFETY IN THE PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga
    Ananyeva, Lidia P.
    Garzanova, Liudmila
    Desinova, Oxana
    Ovsyannikova, Olga
    Starovoytova, Mayya
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 169 - 169
  • [2] Efficacy of Rituximab Versus Cyclophosphamide and Mycophenolate for the Treatment of Interstitial Lung Disease in Systemic Sclerosis: A Systematic Review
    Parikh, Aneri
    Francis, Aida J.
    Sreenivasan, Chithra
    Pandey, Manorama
    AlQassab, Osamah
    Kanthajan, Tatchaya
    AlEdani, Esraa M.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [3] Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide
    Numajiri, Hiroko
    Yoshizaki, Ayumi
    Ebata, Satoshi
    Fukasawa, Takemichi
    Yamashita, Takashi
    Takahashi, Takehiro
    Taniguchi, Takashi
    Asano, Yoshihide
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2018, 45 (06): : E140 - E141
  • [4] Interstitial lung disease associated with systemic sclerosis -: What is the evidence for efficacy of cyclophosphamide?
    Berezne, Alice
    Valeyre, Dominique
    Ranque, Brigitte
    Guillevina, Loic
    Mouthon, Luc
    AUTOIMMUNITY, PT B: NOVEL APPLICATIONS OF BASIC RESEARCH, 2007, 1110 : 271 - 284
  • [5] Effectiveness and Safety of Tacrolimus Following Intravenous Cyclophosphamide Pulse Therapy As the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease
    Ichimura, Yuki
    Kawaguchi, Yasushi
    Takagi, Kae
    Tochimoto, Akiko
    Higuchi, Tomoaki
    Katsumata, Yasuhiro
    Yamanaka, Hisashi
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [6] Cyclophosphamide in Patients with Systemic Sclerosis-associated Interstitial Lung Disease A Systematic Review and Meta-Analysis
    Barnes, Hayley
    Ghazipura, Marya
    Herman, Derrick
    Macrea, Madalina
    Knight, Shandra L.
    Silver, Richard M.
    Montesi, Sydney B.
    Raghu, Ganesh
    Hossain, Tanzib
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (01) : 122 - 135
  • [7] Pulse therapy of cyclophosphamide in treatment of systemic sclerosis with interstitial lung disease
    Damjanov, N
    Palov, S
    Vukovic, I
    Todorovic, N
    Milenkovic, M
    Radunovic, G
    Rebic, P
    JOURNAL OF RHEUMATOLOGY, 2001, 28 : 58 - 58
  • [8] Efficacy of Mycophenolate As a Maintenance Therapy Following the Administration of Cyclophosphamide in the Treatment of Interstitial Lung Disease Associated with Systemic Sclerosis
    Narvaez, Javier
    Borrell Panos, Helena
    Castellvi, Ivan
    Heredia, Sergi
    Millan, Milena
    Herrera, Susana
    Armengol, Eulalia
    Maria LLobet, Josep
    Miquel Nolla, Joan
    Molina, Maria
    Jose Alegre, Juan
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease
    Ebata, Satoshi
    Yoshizaki, Ayumi
    Fukasawa, Takemichi
    Miura, Shunsuke
    Takahashi, Takehiro
    Sumida, Hayakazu
    Asano, Yoshihide
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2019, 46 (11): : 1006 - 1013
  • [10] Effect of Bosentan on Systemic Sclerosis-associated Interstitial Lung Disease Ineligible for Cyclophosphamide Therapy: A Prospective Open-label Study
    Furuya, Yoshiaki
    Kuwana, Masataka
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (10) : 2186 - 2192
12345